Apollo Hospitals Q1 profit rises 34% to ₹581 crore, revenue up 21% YoY
ADVERTISEMENT
Apollo Hospitals Enterprise reported a 34.2% year-on-year rise in consolidated profit attributable to owners to ₹581 crore for the quarter ended June 2026, compared with ₹433 crore in the year-ago period. Consolidated revenue from operations increased 20.6% to ₹7,044 crore from ₹5,842 crore, while EBITDA rose 28.2% to ₹1,092 crore from ₹852 crore. EBITDA margin improved to around 15.5% from 14.6%.
The company said growth was supported by higher inpatient volumes, average revenue per patient (ARPP) and occupancy across its hospital network. As of June 30, Apollo had 8,352 operating beds, excluding Apollo Health and Lifestyle and managed beds, with overall occupancy improving to 70% from 65% a year earlier. Healthcare Services revenue grew 22% to ₹3,567 crore, while EBITDA rose 20% to ₹862 crore.
Dr Prathap C Reddy, founder and chairman, Apollo Hospitals Group, said, “Q1 FY27 marks a strong start to the year, building on the momentum of FY26. Consolidated revenue grew 21% year-on-year to ₹7,043 crore, supported by strong-based performance across Healthcare Services, Diagnostics and Retail Health, and Digital Health and Pharmacy.”
Regional hospitals post broad-based growth
Among regions, AP-Telangana led revenue growth at 31%, with inpatient volumes up 25% and ARPP rising 7% to ₹1,94,605. Western region revenue grew 28%, Karnataka 21%, Eastern 20%, Northern 16% and Tamil Nadu 16%.
The company said its new hospitals in Financial District, Sonarpur, Pune and Delhi Oncology, along with the newly launched Sarjapur facility, had a combined operating capacity of 380 beds and reported an EBITDA loss of ₹38 crore in Q1 FY27.
HealthCo expands pharmacy network
Apollo HealthCo posted 20% revenue growth to ₹2,977 crore, with EBITDA rising to ₹171 crore from ₹94 crore. Offline pharmacy distribution contributed ₹2,629 crore, while the digital platform contributed ₹348 crore. HealthCo added 151 net new stores, taking its network to 7,440 stores.
Apollo 24/7 GMV stood at ₹535 crore, up 23%, while its average daily order run rate increased to 70,000 from 64,000 a year earlier.
Apollo also launched its 180-bed Sarjapur hospital and plans to add more than 5,800 beds over the next five years. Four new hospitals in Indore, Dwarka, Delhi Proton Centre and Ranchi, along with 148 additional beds at existing Indore and Guwahati facilities, account for 1,200 beds of the planned additions.
Reddy said Apollo would remain focused on “clinical excellence and patient safety, preventive and patient-centric care, disciplined expansion and prudent capital allocation.”
The company also disclosed plans to transfer Apollo HealthCo's FMCG, wellness and personal-care wholesale distribution undertaking to wholly owned Apollo Consumer Products through a slump sale, with completion expected by October 1, 2026. The undertaking contributed 14.31% of consolidated turnover in FY26.
Additionally, Apollo Health and Lifestyle's proposed combination with Cloudnine is valued at about ₹1,550 crore enterprise value, subject to regulatory approvals.
Shares of Apollo Hospitals Enterprise ended 1.7% lower at ₹8,597 apiece on the NSE on Wednesday. The stock has risen nearly 19% over the past year, outperforming the benchmark Nifty 50, which slipped more than 0.20% during the same period.